Company logo

CTRE - CareTrust REIT, Inc.

NASDAQ -> Real Estate -> REIT—Healthcare Facilities
San Clemente, United States
Type: Equity

CTRE price evolution
CTRE
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Current assets
Cash $294.45 $3.48 $1.15 $28.07
Short term investments
Net receivables $0.4 $0.38 $0.39 $0.44
Inventory
Total current assets $318.18 $24.6 $15.56 $58.03
Long term investments
Property, plant & equipment $1747.49 $1536.05 $1528.23 $1400.81
Goodwill & intangible assets
Total noncurrent assets
Total investments
Total assets $2084.84 $1767.56 $1736.95 $1622.2
Current liabilities
Accounts payable $33.99 $28.85 $21.04 $24.16
Deferred revenue
Short long term debt
Total current liabilities $70.52 $61.3 $48.88 $52.11
Long term debt $595.6 $595.3 $875.05 $729.77
Total noncurrent liabilities
Total debt $595.6 $595.32 $875.05 $729.77
Total liabilities $666.12 $656.58 $923.93 $781.88
Shareholders' equity
Retained earnings -$467.63 -$457.39 -$433.69 -$405.46
Other shareholder equity
Total shareholder equity $1416.82 $1109.92 $813.02 $840.32
(in millions $) 31 Dec 2023 31 Jan 2023 31 Dec 2021 31 Dec 2020
Current assets
Cash $294.45 $13.18 $19.89 $18.92
Short term investments
Net receivables $0.4 $0.42 $2.42 $1.82
Inventory
Total current assets $318.18 $25.28 $29.82 $31.2
Long term investments
Property, plant & equipment $1747.49 $1577.78 $1605.13 $1463.1
Goodwill & intangible assets
Total noncurrent assets
Total investments
Total assets $2084.84 $1620.78 $1640.85 $1503.56
Current liabilities
Accounts payable $33.99 $24.36 $25.41 $19.57
Deferred revenue
Short long term debt
Total current liabilities $70.52 $51.91 $51.69 $43.9
Long term debt $595.6 $719.5 $673.4 $545.59
Total noncurrent liabilities
Total debt $595.6 $719.5 $673.4 $545.59
Total liabilities $666.12 $771.41 $725.09 $589.42
Shareholders' equity
Retained earnings -$467.63 -$396.95 -$282.05 -$251.21
Other shareholder equity
Total shareholder equity $1416.82 $849.37 $915.76 $914.14
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Revenue
Total revenue $59.73 $55.88 $51.55 $50.61
Cost of revenue $0.56 $1.24 $0.66 $0.96
Gross Profit $59.17 $54.64 $50.9 $49.64
Operating activities
Research & development
Selling, general & administrative $6.51 $5.52 $4.72 $5.06
Total operating expenses $21.45 $20.72 $18.82 $18.18
Operating income $37.72 $33.92 $32.07 $31.46
Income from continuing operations
EBIT $34.56 $20.45 $10.56 $29.05
Income tax expense
Interest expense $8.27 $11.75 $11.04 $9.83
Net income
Net income $26.3 $8.7 -$0.48 $19.23
Income (for common shares) $26.3 $8.7 -$0.48 $19.23
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Revenue
Total revenue $217.77 $196.13 $192.35 $178.33
Cost of revenue $3.42 $5.04
Gross Profit $214.35 $191.09 $192.35 $178.33
Operating activities
Research & development
Selling, general & administrative $21.8 $20.16 $26.87 $16.3
Total operating expenses $79.17 $78.66 $85.79 $71.9
Operating income $135.17 $112.44 $106.56 $106.43
Income from continuing operations
EBIT $94.62 $22.5 $95.66 $104.53
Income tax expense
Interest expense $40.88 $30.01 $23.68 $23.66
Net income
Net income $53.73 -$7.51 $71.98 $80.87
Income (for common shares) $53.73 -$7.51 $71.98 $80.87
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Net income $26.3 $8.7 -$0.48 $19.23
Operating activities
Depreciation $13.23 $13.05 $12.73 $12.25
Business acquisitions & disposals
Stock-based compensation $1.77 $1.52 $0.92 $0.94
Total cash flows from operations $42.67 $45.11 $31.87 $35.12
Investing activities
Capital expenditures -$36.77 -$32.65 -$159.94 -$19.19
Investments -$0.59 -$23.02 -$27.12 $15.14
Total cash flows from investing -$35.51 -$55.66 -$175.83 -$0.82
Financing activities
Dividends paid -$32.4 -$27.84 -$27.84 -$27.41
Sale and purchase of stock $315.41 $319.66 -$0.13 -$0.5
Net borrowings -$0.05 -$280 $145 $9.98
Total cash flows from financing $283.8 $12.89 $117.03 -$19.41
Effect of exchange rate
Change in cash and equivalents $290.96 $2.34 -$26.93 $14.89
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Net income $53.73 -$7.51 $71.98 $80.87
Operating activities
Depreciation $51.26 $50.38 $55.39 $52.82
Business acquisitions & disposals
Stock-based compensation $5.15 $5.76 $10.83 $3.79
Total cash flows from operations $154.77 $144.41 $156.87 $145.74
Investing activities
Capital expenditures -$248.55 -$29.21 -$198.73 -$100.95
Investments -$35.58 -$143.34 -$0.86 $50.43
Total cash flows from investing -$267.81 -$127.4 -$192.63 -$41.58
Financing activities
Dividends paid -$115.49 -$106.14 -$100.78 -$93.16
Sale and purchase of stock $634.45 $47.24 $22.95 -$0.4
Net borrowings -$125.07 $39.64 $115.91 -$10
Total cash flows from financing $394.32 -$23.73 $36.74 -$105.56
Effect of exchange rate
Change in cash and equivalents $281.27 -$6.72 $0.98 -$1.41
Fundamentals
Market cap $3.10B
Enterprise value $3.40B
Shares outstanding 129.99M
Revenue $217.77M
EBITDA $145.88M
EBIT $94.62M
Net Income $53.73M
Revenue Q/Q 15.29%
Revenue Y/Y N/A
P/E ratio 57.60
EV/Sales 15.60
EV/EBITDA 23.28
EV/EBIT 35.89
P/S ratio 14.21
P/B ratio 2.18
Book/Share 10.90
Cash/Share 2.27
EPS $0.41
ROA 2.98%
ROE 5.14%
Debt/Equity 0.47
Net debt/EBITDA 2.55
Current ratio 4.51
Quick ratio 4.51